Related Experiment Videos
Bone turnover markers in patients with osteogenesis imperfecta
Vania Braga1, Davide Gatti, Maurizio Rossini
1Rheumatology Unit, University of Verona, Valeggio S/M, Italy.
Bone
|June 15, 2004
Summary
Osteogenesis imperfecta (OI) is a rare bone disorder. This study found elevated bone turnover markers in adults with OI, suggesting anti-resorptive therapy could be beneficial.
Area of Science:
- Genetics and Molecular Biology
- Endocrinology and Metabolism
- Orthopedics and Bone Research
Background:
- Osteogenesis imperfecta (OI) comprises rare inherited bone disorders affecting collagen synthesis or function.
- Previous studies reported conflicting bone turnover rates in OI patients, potentially due to recent fractures in pediatric cohorts.
- Understanding bone metabolism in adult OI patients without recent fractures is crucial for effective treatment strategies.
Purpose of the Study:
- To assess bone turnover markers in adult patients with various types of Osteogenesis Imperfecta (OI).
- To compare bone metabolism in OI patients to a healthy control group.
- To investigate potential differences in bone markers among different OI types.
Main Methods:
- Serum and urinary bone turnover markers were measured in 77 adult OI patients (39 male, 38 premenopausal female) and 55 healthy controls.
- Markers included total and bone alkaline phosphatase (total and bone AP), serum osteocalcin (sOC), serum type I collagen C-telopeptide breakdown products (sCTX), urinary free-deoxypyridinoline (ufDPD), and urinary cross-linked N-telopeptides of type I collagen (uNTX).
- Patients were selected based on the absence of clinical fractures within 12 months prior to assessment.
Main Results:
- Most bone turnover markers were significantly elevated (50-200%) in OI patients compared to controls.
- Serum CTX levels were comparable between OI patients and controls.
- Patients with OI types III and IV exhibited higher bone resorption markers (ufDPD, uNTX) compared to type I OI, with similar sOC levels to controls.
Conclusions:
- Adults with Osteogenesis Imperfecta demonstrate significantly increased bone turnover, particularly bone resorption.
- Elevated resorption markers in OI types III and IV suggest specific therapeutic targets.
- These findings strongly support the use of anti-resorptive agents for managing Osteogenesis Imperfecta.